Allergies

Differentiating between allergic and non-allergic rhinitis can be challenging as both present with overlapping symptoms like nasal congestion and rhinorrhea. However, several key clinical features can aid in the distinction. Allergic rhinitis typically involves prominent sneezing, itchy nose, and eyes, often accompanied by a clear, watery discharge. Patients may also have a personal or family history of atopy (eczema, asthma, or allergies). Non-allergic rhinitis often presents with similar nasal symptoms, but typically lacks the itchiness and eye involvement. Triggers for non-allergic rhinitis can include irritants like smoke, strong odors, or changes in temperature or humidity. Furthermore, the presence of nasal eosinophilia on a nasal smear can support the diagnosis of allergic rhinitis, while its absence favors non-allergic rhinitis. Consider implementing a thorough patient history, including allergen exposure and symptom patterns, alongside a physical exam focusing on nasal mucosa appearance. Explore how allergy testing, either skin prick or serum IgE, can be useful in confirming the presence of allergen sensitization in suspected allergic rhinitis cases. Learn more about the specific clinical features of various non-allergic rhinitis subtypes to enhance diagnostic accuracy.

For adult patients with persistent allergic rhinitis experiencing inadequate symptom control despite using intranasal corticosteroids, several evidence-based treatment strategies can be considered. Adding a second-generation oral antihistamine, such as loratadine or cetirizine, can provide additional relief from itching, sneezing, and rhinorrhea. Leukotriene receptor antagonists, like montelukast, can be beneficial, particularly for patients with concomitant asthma. For severe cases, adding intranasal anticholinergics, like ipratropium bromide, can help control rhinorrhea. Immunotherapy, either subcutaneous or sublingual, represents a disease-modifying approach for persistent allergic rhinitis, targeting the underlying allergic sensitization and potentially offering long-term remission. Explore how newer biologic therapies targeting specific inflammatory mediators, such as IgE or IL-5, are emerging as options for severe, refractory allergic rhinitis. Consider implementing a step-up approach to treatment, starting with intranasal corticosteroids and progressively adding other medications based on symptom control and patient response. Learn more about the efficacy and safety profiles of each treatment option to personalize the management plan.

Referral to an allergist is warranted for patients with suspected allergic rhinitis when symptoms are severe, persistent, and impacting quality of life despite initial management. Key referral criteria based on current guidelines include uncontrolled symptoms despite appropriate use of intranasal corticosteroids and other first-line therapies, diagnostic uncertainty or consideration of alternative diagnoses, suspicion of comorbid conditions like asthma or sinusitis, and consideration of immunotherapy. Additionally, patients experiencing adverse effects from prescribed medications or those with complex or unusual presentations warrant specialist evaluation. Explore how allergy testing performed by an allergist can identify specific allergens triggering symptoms, enabling personalized avoidance strategies and tailored immunotherapy if indicated. Consider implementing a shared decision-making approach with the patient, discussing the benefits and risks of referral and empowering them in the management process. Learn more about the latest guidelines and best practices for managing allergic rhinitis to ensure optimal patient care.